News
A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...
Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...
Myelodysplastic Syndrome Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current myelodysplastic ...
6d
Zacks Investment Research on MSNIncyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the ...
Investigation reveals global distribution of bad cancer drugs, highlighting risks and challenges in ensuring drug quality ...
Bernard Mahon was initially refused access to treatment with pembrolizumab by his private health insurer, Laya Healthcare, before running a social media campaign to raise awareness about it ...
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...
Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...
The worst-performing drug in the study is made by Indian manufacturer Venus Remedies. It is called cyclophosphamide, a drug ...
Scientists discover how cells absorb queuosine, a vital nutrient affecting memory, learning, and cancer resistance.
Once a suspect COVID cure, now a right-wing aspirin. As a physician who diagnoses cancer, I have come across this line of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results